Company Filing History:
Years Active: 2015-2021
Title: Jason B Ibarra: Innovator in Pharmaceutical Modulation
Introduction
Jason B Ibarra is a prominent inventor based in Las Vegas, NV (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that modulate the prostacyclin receptor. With a total of 8 patents to his name, Ibarra's work is focused on addressing various medical disorders.
Latest Patents
Ibarra's latest patents include innovative compounds such as pyrazolyl substituted carbonic acid derivatives. These compounds serve as modulators of the prostacyclin (PGI2) receptor and are useful in treating a range of disorders. His inventions target conditions like pulmonary arterial hypertension (PAH), coronary artery disease, and various inflammatory diseases. Another notable patent involves substituted pyridazines and 1,2,4-triazines, which also act as prostacyclin receptor modulators, further expanding the therapeutic applications of his research.
Career Highlights
Ibarra is currently associated with Arena Pharmaceuticals, Inc., where he continues to push the boundaries of pharmaceutical innovation. His work has been instrumental in developing treatments for serious health conditions, showcasing his commitment to improving patient outcomes through scientific advancement.
Collaborations
Throughout his career, Ibarra has collaborated with talented individuals such as Thuy-Anh Tran and Brett Ullman. These partnerships have fostered a collaborative environment that enhances the innovation process and leads to groundbreaking discoveries.
Conclusion
Jason B Ibarra stands out as a key figure in pharmaceutical innovation, with a focus on developing life-changing treatments. His contributions to the field are marked by a dedication to addressing complex medical challenges through innovative solutions.